Animal, Dairy & Veterinary Sciences
Adjunct Associate Professor
Dr. Wu conducted her postdoctoral research in the Department of Cell Biology at Harvard Medical School. She received her Ph.D. in molecular and cellular biology from University of Massachusetts at Amherst, and her M.S. in biochemistry and her B.S. in molecular biology from Jilin University in China.
Dr. Wu is the Senior Vice President of Vaccine and Antibody Development at SAB Biotherapeutics, USA. She oversees the research on vaccine formulations, immunization strategies, and in vitro potency evaluations and in vivo efficacy studies of disease-targeted human therapeutic antibodies produced from transchromosomic (Tc) bovine. Dr. Wu also directs bioanalytic assay development, qualification and sample testing for preclinical studies and human clinical trials. Since 2004, Dr. Wu has been leading numerous projects for the development of Tc bovine-derived fully human therapeutic antibodies targeting cancer and infectious diseases, such as MERS CoV, Influenza, Zika, Mycoplasma hominis, Ebola, Marburg, Alphaviruse, Hanta, Dengue, Anthrax, MRSA, SARS, and Botulinum toxin.